100 Participants Needed

Dietary and Behavioral Changes for Metabolic Syndrome

(SUSTAIN Trial)

EF
JJ
Overseen ByJoshua Joseph
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ohio State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment SUSTAIN for metabolic syndrome?

The research highlights that lifestyle changes, including diet and exercise, are effective in improving metabolic syndrome. These changes can reduce weight, improve blood pressure, and lower cholesterol levels, which are key components of metabolic syndrome.12345

Is the treatment for metabolic syndrome safe for humans?

Lifestyle changes like diet and exercise, which are part of the treatment for metabolic syndrome, are generally safe and have been shown to improve health by reducing risk factors like high blood pressure and high cholesterol.13678

How does the SUSTAIN treatment differ from other treatments for metabolic syndrome?

The SUSTAIN treatment is unique because it focuses on dietary and behavioral changes to address metabolic syndrome, emphasizing lifestyle modifications like diet and exercise, which can significantly improve or even reverse the condition. Unlike some treatments that rely on medication, SUSTAIN targets the root behavioral causes of metabolic syndrome, promoting long-term health improvements through sustainable lifestyle changes.134910

What is the purpose of this trial?

To determine the feasibility and engagement of participants in the SUSTAIN intervention compared to enhanced usual care over 24 weeks through mixed-methods measurement of participant enrollment, adherence, retention, and engagement (counseling, screenings, referrals, and uptake). Methods: Leveraging rigorous quantitative and qualitative evaluation, the study team will identify mechanisms driving intervention feasibility and engagement. Hypothesis: SUSTAIN will be feasible with a high degree of engagement among Medicaid-enrolled participants with Stage 2 CKMS in comparison to enhanced usual care.

Research Team

JJ

Joshua J Joseph, MD

Principal Investigator

Ohio State University

Eligibility Criteria

The SUSTAIN trial is for individuals with Stage 2 Chronic Kidney Disease Metabolic Syndrome (CKMS), who are also enrolled in Medicaid. It's designed to help those at risk of cardiovascular disease by improving their nutrition and behavior related to health.

Inclusion Criteria

I have been diagnosed with hypertension, type 2 diabetes, high cholesterol, kidney disease, or metabolic syndrome.
Patient must have access to internet-enabled device
I am willing to use my credit card for backup payments on Instacart.
See 3 more

Exclusion Criteria

Any comorbidity such as psychiatric or general illness that may put the subject at risk as determined by investigator
Any other factor which, in the investigator's opinion, is likely to compromise the subject's ability to participate in the study
Recent (e.g., 6 months) participation in other behavioral nutrition trials
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Intervention Phase 1

Participants receive Instacart groceries (voucher + delivery fees), access to the Mid-Ohio Farmacy Program, behavioral nutrition counseling, and social needs screening and referrals

8 weeks
Weekly visits (virtual or in-person)

Intervention Phase 2

Participants receive Instacart groceries (delivery fees only), access to the Mid-Ohio Farmacy Program, behavioral nutrition counseling, and social needs screening and referrals

8 weeks
Weekly visits (virtual or in-person)

Intervention Phase 3

Participants receive Instacart access (no financial support), access to the Mid-Ohio Farmacy Program, and social needs screening and referrals

8 weeks
Weekly visits (virtual or in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
2 visits (in-person)

Treatment Details

Interventions

  • SUSTAIN
Trial Overview This study tests a program called SUSTAIN, which includes dietary changes through Mid-Ohio Farmacy access, Instacart vouchers, behavioral counseling, Health Impact Ohio Hub access, cooking classes, and covering delivery fees. It compares this approach to the usual care over six months.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Intervention GroupExperimental Treatment6 Interventions
Weeks 1-8: The intervention group will receive Instacart groceries (voucher + delivery fees), access to the Mid-Ohio Farmacy Program, behavioral nutrition counseling, and social needs screening and referrals. Weeks 9-16: The intervention group will receive Instacart groceries (delivery fees only), access to Mid-Ohio Farmacy program, behavioral nutrition counseling and social needs screening and referrals. Weeks 17-24: The intervention group will receive Instacart access (no financial support), access to the Mid-Ohio Farmacy Program and social needs screening and referrals.
Group II: Control GroupExperimental Treatment3 Interventions
Weeks 1-8: The control group will receive Instacart groceries (voucher + delivery fees) and access to the Mid-Ohio Farmacy program. Weeks 9-16: The control group will receive Instacart groceries (delivery fees only) and access to the Mid-Ohio Farmacy program. Weeks 17-24: The control group will receive Instacart access (no financial support) and access to the Mid-Ohio Farmacy program.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials
891
Recruited
2,659,000+

American Heart Association

Collaborator

Trials
352
Recruited
6,196,000+

Findings from Research

The metabolic syndrome is a major risk factor for cardiovascular disease, diagnosed based on criteria like obesity, high blood pressure, and insulin resistance, highlighting the need for effective dietary interventions.
Current dietary strategies for managing metabolic syndrome should focus on reducing energy intake, increasing physical activity, and balancing macronutrients, while emphasizing long-term support and group therapy to address individual risk factors.
[Metabolic syndrome: diagnosis and dietary intervention].Eisenlohr, H.[2018]
The metabolic syndrome is rapidly increasing globally, and effective prevention and treatment focus on lifestyle changes such as a healthy diet and regular physical activity, along with medications targeting specific risk factors.
Weight loss is crucial for improving all aspects of the metabolic syndrome and is a primary target for intervention, with successful long-term management relying on strategies like setting realistic goals and providing support.
Need for lifestyle intervention: how to begin.Foreyt, JP.[2018]
Metabolic syndrome, characterized by a combination of high triglycerides, low HDL cholesterol, high blood pressure, impaired glucose tolerance, and central obesity, is becoming a leading risk factor for heart disease in the U.S., surpassing smoking.
Effective management of metabolic syndrome includes lifestyle interventions such as diet and exercise, with weight loss improving all aspects of the syndrome; specific dietary changes can target individual risk factors, like reducing saturated fats for insulin resistance and sodium for blood pressure.
Metabolic syndrome: time for action.Deen, D.[2017]

References

[Metabolic syndrome: diagnosis and dietary intervention]. [2018]
Need for lifestyle intervention: how to begin. [2018]
Metabolic syndrome: time for action. [2017]
Health promotion in older adults: the role of lifestyle in the metabolic syndrome. [2017]
Effect of the telephone-delivered nutrition education on dietary intake and biochemical parameters in subjects with metabolic syndrome. [2021]
Mediterranean diet and the metabolic syndrome. [2017]
Epidemiology of the metabolic syndrome. [2022]
Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. [2022]
Promoting only the consumption of healthy foods may be an alternative stategy for treating patients with the metabolic syndrome. [2017]
Metabolic syndrome: are we at risk? [2017]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security